British Scientists Get Permission To Genetically Modify Embryos

Video highlights from Breakthrough

Researchers will examine how an embryo’s genes affect its survival in the first week of life

Scientists in Britain have been given the go-ahead to genetically modify embryos for the first time in the United Kingdom and the second time in the world.

The researchers at The Francis Crick Institute in London, who originally sought approval in September last year, will use the CRISPR DNA editing technique to determine how an embryo’s genes impact its survival in the first week of life.

'We would really like to understand the genes needed for a human embryo to develop successfully into a healthy baby,” says Dr Kathy Niakan, who will lead the research.

“The reason why it is so important is because miscarriages and infertility are extremely common, but they're not very well understood.”

LEARN MORE: 5 Reasons Gene Editing Is Both Terrific And Terrifying

The findings could offer significant insight into recurrent miscarriages and increase the chances of IVF success, but critics say the technology could be used to build designer babies.

Dr David King, the director of Human Genetics Alert, says, “This research will allow the scientists to refine the techniques for creating genetically modified babies, and many of the Government’s scientific advisors have already decided that they are in favour of doing that,”

“This is the first step in a well mapped-out process leading to GM babies, and a future of consumer eugenics.”

The Human Fertilisation and Embryology Authority, who approved the research, have emphasised that the embryos can only be used for basic research and cannot be implanted in women.

Discuss this article


Never miss a Nat Geo moment

Your email address
We use our own and third-party cookies to improve our services, personalise your advertising and remember your preferences. If you continue browsing, or click on the accept button on this banner, we understand that you accept the use of cookies on our website. For more information visit our Cookies Policy AcceptClose cookie policy overlay